Kintor Pharmaceutical Limited reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was CNY 1,060.82 million compared to CNY 954.37 million a year ago. Basic loss per share from continuing operations was CNY 2.47 compared to CNY 2.53 a year ago.

Diluted loss per share from continuing operations was CNY 2.47 compared to CNY 2.53 a year ago.